Medtronic has reported late-breaking data from the Evolut Low Risk Trial's five-year outcomes of the Evolut TAVR system. The post Medtronic reports late-breaking data from TAVR system trial for aortic stenosis appeared first on Medical Device Network.
Medtronic is an Ireland-based medical device company that manufactures and supplies therapeutic and diagnostic equipment to treat chronic diseases across the globe.